Know Cancer

or
forgot password

Monitoring Cellular Immunity After Kidney and Liver Transplantation


N/A
18 Years
N/A
Open (Enrolling)
Both
Terminal Kidney Failure, Terminal Liver Failure

Thank you

Trial Information

Monitoring Cellular Immunity After Kidney and Liver Transplantation


Inclusion Criteria:



- All patients undergoing kidney or liver transplantation at the Karolinska University
Hospital

Exclusion Criteria:

- Abscence of informed consent

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

T cell reactivity to viral antigens

Outcome Time Frame:

Pre-transplantation and 2 weeks, 1, 3, 6 and 12 months after transplantation

Safety Issue:

No

Principal Investigator

Lars Wennberg, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Karolinska University Hospital

Authority:

Sweden: Institutional Review Board

Study ID:

T cell study

NCT ID:

NCT00683748

Start Date:

March 2007

Completion Date:

March 2009

Related Keywords:

  • Terminal Kidney Failure
  • Terminal Liver Failure
  • Transplantation
  • Immunological monitoring
  • Immunological risk
  • T cell reactivity
  • Cellular immunity
  • Renal Insufficiency
  • Liver Failure

Name

Location